Clinical Trials Browser

Phase 3 × Inotuzumab Ozogamicin × 30 days × Clear all

NCT03150693 2026-06-02

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Phase 3 Recruiting

Burkitt Lymphoma